osmotherapy use osmotically active substances reduce volume intracranial contents osmotherapy serves primary medical treatment cerebral edema primary purpose osmotherapy improve elasticity decrease intracranial volume removing free water accumulated result cerebral edema brains extracellular intracellular space vascular compartment creating osmotic gradient blood brain normal serum osmolality ranges mosmkg serum osmolality cause water removal brain without much side effects ranges mosmkg usually ml space created intracranial vault reduction brain water osmotherapy cerebral dehydrating main goal osmotherapy decrease intracranial pressure icp shifting excess fluid brain accomplished intravenous administration osmotic agents increase serum osmolality order shift excess fluid intracellular extracellular space brain intravascular compartment resulting brain shrinkage effectively reduces intracranial volume decreases weed mckibben biomedical researchers johns hopkins medical school first ones document use effect osmotically active substances brain mass studying transfer salt solutions blood cerebrospinal fluid csf first noted concentrated sodium chloride intravenous iv injection led collapse thecal sac prevented withdrawing csf lumbar cistern order study effect conducted lab experiments anesthetized cats underwent craniotomy observed changes convexity cats brain upon iv injection specifically noted hypertonic saline iv injection resulted maximum shrinkage brain mins administration hypotonic solutions resulted protrusion rupture brain tissue use osmotic agents iv delivery became increase cerebral water content called cerebral edema usually results traumatic brain injury tbi subarachnoid hemorrhage sah intracerebral hemorrhage ich subdural hematoma ischemic stroke brain tumors infectious disorders intracranial surgery cerebral edema may result compromised regional cerebral blood flow cbf intracranial pressure icp gradients could lead death increased icp leads increased intracranial volume unmonitored icp leads brain damage global hypoxic ischemic injury due reduction cerebral perfusion pressure cpp found subtracting icp mean arterial pressure map cerebral blood flow mechanical compression brain tissue due compartmentalized icp cerebral edema mainly classified cytotoxic edema vasogenic edema interstitial edema cytotoxic edema affects white gray matter results swelling cellular elements neurons glia endothelial cells vasogenic edema affects white matter results blood brain barrier bbb breakdown interstitial edema results lack proper cerebrospinal fluid csf osmotic agents work primarily affecting blood brain important osmotic agents cross blood brain barrier main idea use osmotic agents increase plasma osmolarity cause osmotic gradient cause water brain cells flow plasma equilibrium reached icp intracellular volume return initial normal ideal osmotic agent would characterized inertness relative nontoxicity complete exclusion brain entry thus osmotic agents reflection coefficient Ïƒ closer freely permeable completely impermeable preferred likely exhibit rebound effects cerebral edema icp elevations upon withdrawal commonly used osmotic agents urea glycerol mannitol hypertonic dosage osmotic agent administration referred grams per persons body mass g urea introduced due low molecular weight slow penetration bbb however cause rebound effects side effects intravascular hemolysis urea administered dosage gkg gkg glycerol introduced likelihood exhibiting rebound effects causing side effects hemolysis hemoglobinuria renal failure hyperosmolar coma glycerol used dosage gkg followed gkg mannitol alcohol derivative simple sugar mannose use investigated since molecular weight daltons half life hours ease preparation chemical stability free radical scavenging properties regarded principal osmotic agent clinical use however could cause diuresis renal failure hyperkalemia mannitol administered dosage used mannitol solution gkg followed gkg doses needed every hours depending hypertonic saline interest since early hypertonic saline contains sodium chloride works regulating icp intravascular volume cardiac output without causing significant diuresis theoretical side effects ranging neurological complications subdural hematoma hypertonic saline solution choice neuro critical care past hypertonic saline solution used varies could saline hypertonic solution administered dosage currently osmotherapy way reduce cerebral edema hypertonic saline appears better osmotic agents according researchers glycerol best administered basal treatment whereas mannitol administered control sudden rises compared mannitol theres evidence improvement icp cerebral blood flow cpp due administration hypertonic saline lasts longer addition hypertonic saline also shows significant effect improving blood rheology hematocrit shear rate level internal carotid artery research studies going find efficient mechanisms treat cerebral edema combining osmotherapy treatment mechanisms greater potential treat cerebral edema serious pathological effects effectively reductive ventricular omotherapy rvot could novel treatment manages cerebral edema without use osmotic agents rvot uses catheters permeable water vapor increase osmolarity csf ex vivo experiments carried test efficiency rvot rvot done locally therefore likely efficient severe cases cerebral edema sweep gas gas used flow hollow fiber flows rvot catheter made hollow fiber semipermeable walls remove free unbound water ventricles form water osmotherapy using osmotic agents fails treating cerebral edema therapies using barbiturates corticosteroids could developed barbiturates like pentobarbital act like free radical scavengers well decrease intracranial blood volume reducing cerebral metabolic demand however administration barbiturates poses risks hypotension induced coma infection limiting potential clinical application although corticosteroids effective treating cerebral edema resulting ischemic stroke intracerebral hemorrhage effective treating vasogenic edema resulting brain tumors idea behind administration barbiturates corticosteroids provide space cerebral swelling resulting edema thus non specific treating research focuses identifying novel targets prevents formation cerebral edema order develop strategies prevent cerebral edema important understand cerebral edema molecular level targets identified includes channel vasopressin receptor early reperfusion stage ischemia upregulation secondary active cotransporter nkccl nkccl play important role modulating loading sodium chloride neurons glia endothelial cells choroid plexus upregulation nkccl followed increased deposition sodium chloride endothelial cells nakatpase activity plays role expelling na followed chloride water endothelial cells extracellular space leading vasogenic edema thus preventing nkccl upregulation potential prevent cerebral edema forming bumetanide delivered across blood brain barrier inhibitor bumetanide significantly reduces inflammation resulting identifying right dose bumetanide acts inhibitor nkccl could prevent cerebral edema extent represents atp dependent stage cerebral edema upregulation nonselective cation channel followed brain tumor ischemic injury traumatic brain injury channel activated atp depletion found neurons neuroglia endothelium channel enables passive transport water solute represents atp independent stage cerebral formation opening channels result cellular depolarization blebbing causing cytotoxic edema prevented using glyburide glibenclamide inhibits vasopressin receptors activated vasopressin found basolateral membrane cells lining collecting ducts kidneys aneurysmal subarachnoid hemorrhage asah results hyponatremia leads water retention antidiuretic hormone release causing increase intracranial pressure formation cerebral edema prevented administration conivaptan safe fda approved drug treats euvolemic hyponatremia process aquaresis conivapten vasopressin receptor antagonist improves serum sodium concentration eliminating free water without negative effect systolic blood pressure pulse rate since decrease cerebral volume icp potential treat many forms cerebral httpsenwikipediaorgwikiosmotherapy